ARTICLE | Clinical News
Intranasal sumatriptan powder: Additional Phase IIIb data
July 27, 2015 7:00 AM UTC
Additional data from the double-blind, double-dummy, crossover, U.S. Phase IIIb COMPASS trial in 275 patients with acute migraine with or without aura showed that 22 mg intranasal AVP-825 improved the...